Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 02, 2021 at 07:56 am EDT
Share
Jafron Biomedical Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,188.254 million compared to CNY 869.675 million a year ago. Operating income was CNY 731.370 million compared to CNY 530.086 million a year ago. Net income was CNY 620.140 million compared to CNY 440.629 million a year ago. Basic earnings per share from continuing operations was CNY 0.78 compared to CNY 0.55 a year ago. Diluted earnings per share from continuing operations was CNY 0.77 compared to CNY 0.55 a year ago.
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.
JAFRON BIOMEDICAL CO.,LTD. 
